Showing results (441-450 of 1,503) with videos related to
Sort By:
Pageof 151
The Lancet. Global Health|February 23, 2015
Health of men, women, and children in post-trafficking services in Cambodia, Thailand, and Vietnam: an observational cross-sectional studyLigia Kiss, Nicola S Pocock, Varaporn Naisanguansri, et al.The Lancet. Global Health|February 23, 2015
Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort studySabin Nsanzimana, Eric Remera, Steve Kanters, et al.The Lancet. Global Health|April 29, 2023
Incidence and outcomes for stroke in Ulaanbaatar, Mongolia, during 2019-21: a prospective population-based studyChimeglkham Banzrai, Oyungerel Bosookhuu, Erdenechimeg Yadamsuren, et al.The Lancet. Global Health|May 18, 2023
Health service quality in 2929 facilities in six low-income and middle-income countries: a positive deviance analysisTodd P Lewis, Margaret McConnell, Amit Aryal, et al.The Lancet. Global Health|May 18, 2023
The impact of ivermectin, diethylcarbamazine citrate, and albendazole mass drug administration on the prevalence of scabies and soil-transmitted helminths in school-aged children in three municipalities in Timor-Leste: a before-after assessmentBrandon Le, Merita Antonia Armindo Monteiro, Salvador Amaral, et al.The Lancet. Global Health|July 26, 2020
Achieving coordinated national immunity and cholera elimination in Haiti through vaccination: a modelling studyElizabeth C Lee, Dennis L Chao, Joseph C Lemaitre, et al.The Lancet. Global Health|August 23, 2020
Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000-17The Lancet. Global Health|August 23, 2020
Real-world effectiveness of rotavirus vaccines, 2006-19: a literature review and meta-analysisEleanor Burnett, Umesh D Parashar, Jacqueline E TateThe Lancet. Global Health|August 23, 2020
Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trialVijay Patil, Vanita Noronha, Sachin Babanrao Dhumal, et al.The Lancet. Global Health|April 18, 2021
Multimonth dispensing of up to 6 months of antiretroviral therapy in Malawi and Zambia (INTERVAL): a cluster-randomised, non-blinded, non-inferiority trialRisa M Hoffman, Crispin Moyo, Kelvin T Balakasi, et al.Pageof 151